cui1,cui2,relation,name1,name2,type1,type2,weight,predicate
C0001637,C0232341,TREATS,Adrenergic Agents,Increased vascular flow,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0001640,C0020649,TREATS,Adrenergic alpha-Agonists,Hypotension,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0001644,C0349790,TREATS,Adrenergic beta-Agonists,Exacerbation of asthma,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0001644,C0743630,TREATS,Adrenergic beta-Agonists,exacerbation acute,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0001645,C0035213,TREATS,Adrenergic beta-Antagonists,Pulmonary Ventilation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0001645,C0035648,TREATS,Adrenergic beta-Antagonists,risk factors,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0001645,C0150312,TREATS,Adrenergic beta-Antagonists,Present,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0001645,C0600061,TREATS,Adrenergic beta-Antagonists,Serum creatinine level,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0001645,C1444662,TREATS,Adrenergic beta-Antagonists,Discontinued,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0001645,C3276943,TREATS,Adrenergic beta-Antagonists,"Hypertension, mild",phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0001645,C3842676,TREATS,Adrenergic beta-Antagonists,Day 2,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0001648,C0422815,TREATS,Adrenergic Agonists,Urethral function,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0001648,C0700292,TREATS,Adrenergic Agonists,Hypoxemia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0001648,C0743630,TREATS,Adrenergic Agonists,exacerbation acute,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0002932,C0235195,TREATS,Anesthetics,Sedated state,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0003015,C0001925,TREATS,Angiotensin-Converting Enzyme Inhibitors,Albuminuria,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003015,C0009488,TREATS,Angiotensin-Converting Enzyme Inhibitors,Comorbidity,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0003015,C0020649,TREATS,Angiotensin-Converting Enzyme Inhibitors,Hypotension,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003015,C0087130,TREATS,Angiotensin-Converting Enzyme Inhibitors,Uncertainty,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003015,C0150312,TREATS,Angiotensin-Converting Enzyme Inhibitors,Present,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0003015,C0241863,TREATS,Angiotensin-Converting Enzyme Inhibitors,diabetic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003015,C3151529,TREATS,Angiotensin-Converting Enzyme Inhibitors,Lethal,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003015,C3272283,TREATS,Angiotensin-Converting Enzyme Inhibitors,American College of Cardiology/American Heart Association Lesion Complexity Score C,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003015,C3714738,TREATS,Angiotensin-Converting Enzyme Inhibitors,Compliance,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003015,C3869937,TREATS,Angiotensin-Converting Enzyme Inhibitors,T1d,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003015,C4013784,TREATS,Angiotensin-Converting Enzyme Inhibitors,"Hypertension, severe",phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003158,C0221198,TREATS,Anthelmintics,Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003158,C0237677,TREATS,Anthelmintics,insensitivity,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003158,C0679252,TREATS,Anthelmintics,cure of disease,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003191,C0332149,TREATS,Antirheumatic Agents,Possible,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003195,C0003811,TREATS,Anti-Arrhythmia Agents,Cardiac Arrhythmia,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0003195,C0518609,TREATS,Anti-Arrhythmia Agents,consideration,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003204,C0439663,TREATS,Anti-Infective Agents,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C0009940,TREATS,Anti-Inflammatory Agents,Convalescence,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C0026858,TREATS,Anti-Inflammatory Agents,Musculoskeletal Pain,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C0033687,TREATS,Anti-Inflammatory Agents,Proteinuria,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C0033774,TREATS,Anti-Inflammatory Agents,Pruritus,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0003209,C0151602,TREATS,Anti-Inflammatory Agents,Facial swelling (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C0240320,TREATS,Anti-Inflammatory Agents,medication use,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C0439663,TREATS,Anti-Inflammatory Agents,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C0442797,TREATS,Anti-Inflammatory Agents,Decreasing,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C0522568,TREATS,Anti-Inflammatory Agents,Moderate inflammation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C0748864,TREATS,Anti-Inflammatory Agents,small size,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C1301624,TREATS,Anti-Inflammatory Agents,Medical contraindication,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C1545588,TREATS,Anti-Inflammatory Agents,Protection,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0003209,C1836348,TREATS,Anti-Inflammatory Agents,Severe disorder,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C1836407,TREATS,Anti-Inflammatory Agents,Early death,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C3687252,TREATS,Anti-Inflammatory Agents,Eosinophilic inflammation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C4086268,TREATS,Anti-Inflammatory Agents,Exacerbation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003209,C4321237,TREATS,Anti-Inflammatory Agents,High Level,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003211,C0026858,TREATS,"Anti-Inflammatory Agents, Non-Steroidal",Musculoskeletal Pain,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0003211,C0150312,TREATS,"Anti-Inflammatory Agents, Non-Steroidal",Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003211,C0158915,TREATS,"Anti-Inflammatory Agents, Non-Steroidal",Exceptionally large baby (disorder),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003211,C0277786,TREATS,"Anti-Inflammatory Agents, Non-Steroidal",Chief complaint (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003211,C0436345,TREATS,"Anti-Inflammatory Agents, Non-Steroidal",Symptom severe,phsu,fndg,4,TREATS_PHSUtrtsFNDG
C0003211,C1281905,TREATS,"Anti-Inflammatory Agents, Non-Steroidal",At risk of disease,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003211,C1299586,TREATS,"Anti-Inflammatory Agents, Non-Steroidal",Has difficulty doing (qualifier value),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003280,C0009488,TREATS,Anticoagulants,Comorbidity,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003280,C0442797,TREATS,Anticoagulants,Decreasing,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003280,C0742969,TREATS,Anticoagulants,D-dimer above reference range,phsu,fndg,3,TREATS_PHSUtrtsFNDG
C0003280,C3272283,TREATS,Anticoagulants,American College of Cardiology/American Heart Association Lesion Complexity Score C,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003286,C0259752,TREATS,Anticonvulsants,Hyperosmolarity,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003289,C0332149,TREATS,Antidepressive Agents,Possible,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003289,C0424594,TREATS,Antidepressive Agents,Frailty,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003289,C0518609,TREATS,Antidepressive Agents,consideration,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003289,C0682132,TREATS,Antidepressive Agents,regional difference,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003290,C0043094,TREATS,Tricyclic Antidepressive Agents,Weight Gain,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003292,C0150312,TREATS,Antidiarrheals,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003295,C0239157,TREATS,Antidote,cyanide exposure,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003295,C0728899,TREATS,Antidote,Intoxication,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0003297,C3714738,TREATS,Antiemetics,Compliance,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003299,C0043094,TREATS,Antiepileptic Agents,Weight Gain,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003299,C1299590,TREATS,Antiepileptic Agents,Seizure free,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003308,C0205160,TREATS,Antifungal Agents,Negative,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003308,C0442751,TREATS,Antifungal Agents,Distance vision 6/9,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003308,C0728731,TREATS,Antifungal Agents,Prematurity of fetus,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003308,C3272283,TREATS,Antifungal Agents,American College of Cardiology/American Heart Association Lesion Complexity Score C,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003364,C0033687,TREATS,Antihypertensive Agents,Proteinuria,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003364,C0242350,TREATS,Antihypertensive Agents,Erectile dysfunction,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003364,C0424589,TREATS,Antihypertensive Agents,Vitality,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003364,C3843647,TREATS,Antihypertensive Agents,> 2 years,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003364,C4013784,TREATS,Antihypertensive Agents,"Hypertension, severe",phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003374,C0038002,TREATS,Antimalarials,Splenomegaly,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003374,C0150312,TREATS,Antimalarials,Present,phsu,fndg,3,TREATS_PHSUtrtsFNDG
C0003374,C0205160,TREATS,Antimalarials,Negative,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003374,C0439663,TREATS,Antimalarials,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003374,C1856381,TREATS,Antimalarials,Glucose-6-phosphate deficiency,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003374,C3845888,TREATS,Antimalarials,Known allergy,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003374,C4313322,TREATS,Antimalarials,Alveolar damage,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003385,C0231337,TREATS,Muscarinic Antagonists,Senility,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003402,C0086565,TREATS,Antioxidants,Liver Dysfunction,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003402,C0150312,TREATS,Antioxidants,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003402,C0241863,TREATS,Antioxidants,diabetic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003402,C0278252,TREATS,Antioxidants,Prognosis bad,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003402,C1545588,TREATS,Antioxidants,Protection,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003402,C2748212,TREATS,Antioxidants,Viral titer Reduction,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003402,C3872830,TREATS,Antioxidants,Inflammatory lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003402,C4540229,TREATS,Antioxidants,Mitochondrial oxidative stress,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003419,C0231262,TREATS,Antipyretics,Temperature normal,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003419,C0242350,TREATS,Antipyretics,Erectile dysfunction,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003419,C0439663,TREATS,Antipyretics,Infected,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0003419,C0456240,TREATS,Antipyretics,Core body temperature,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003419,C1275743,TREATS,Antipyretics,Co-morbid conditions,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003419,C1317600,TREATS,Antipyretics,patient symptoms,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003448,C0150312,TREATS,Antitubercular Agents,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003448,C0750484,TREATS,Antitubercular Agents,Confirmation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003449,C1317600,TREATS,Antitussive Agents,patient symptoms,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C0035648,TREATS,Antiviral Agents,risk factors,phsu,fndg,4,TREATS_PHSUtrtsFNDG
C0003451,C0085393,TREATS,Antiviral Agents,Immunocompromised Host,phsu,fndg,12,TREATS_PHSUtrtsFNDG
C0003451,C0150312,TREATS,Antiviral Agents,Present,phsu,fndg,4,TREATS_PHSUtrtsFNDG
C0003451,C0205160,TREATS,Antiviral Agents,Negative,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C0231224,TREATS,Antiviral Agents,Crisis,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C0332149,TREATS,Antiviral Agents,Possible,phsu,fndg,3,TREATS_PHSUtrtsFNDG
C0003451,C0418624,TREATS,Antiviral Agents,Nonadministration of necessary drug or medicine,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C0439662,TREATS,Antiviral Agents,Immune,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C0439663,TREATS,Antiviral Agents,Infected,phsu,fndg,21,TREATS_PHSUtrtsFNDG
C0003451,C0442797,TREATS,Antiviral Agents,Decreasing,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C0677946,TREATS,Antiviral Agents,Stable Disease,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C0683320,TREATS,Antiviral Agents,unwellness,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0003451,C0701159,TREATS,Antiviral Agents,Patient in hospital,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C0750484,TREATS,Antiviral Agents,Confirmation,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0003451,C1148363,TREATS,Antiviral Agents,Hepatitis C virus genotype (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C1273390,TREATS,Antiviral Agents,curative treatment,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C1299586,TREATS,Antiviral Agents,Has difficulty doing (qualifier value),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C1545588,TREATS,Antiviral Agents,Protection,phsu,fndg,4,TREATS_PHSUtrtsFNDG
C0003451,C1836348,TREATS,Antiviral Agents,Severe disorder,phsu,fndg,6,TREATS_PHSUtrtsFNDG
C0003451,C2945640,TREATS,Antiviral Agents,compromise,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C3272283,TREATS,Antiviral Agents,American College of Cardiology/American Heart Association Lesion Complexity Score C,phsu,fndg,6,TREATS_PHSUtrtsFNDG
C0003451,C3540840,TREATS,Antiviral Agents,Sign or Symptom,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C3811922,TREATS,Antiviral Agents,Liver transplant recipient,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C3842676,TREATS,Antiviral Agents,Day 2,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C3846017,TREATS,Antiviral Agents,Life threatening illness,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0003451,C4086268,TREATS,Antiviral Agents,Exacerbation,phsu,fndg,3,TREATS_PHSUtrtsFNDG
C0004110,C0392209,TREATS,Astringents,Nutritional status,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0004906,C0581124,TREATS,Beclomethasone Dipropionate,Mild asthma,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0004906,C3687252,TREATS,Beclomethasone Dipropionate,Eosinophilic inflammation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0006280,C0021294,TREATS,Bronchodilator Agents,"Infant, Premature",phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0006280,C0035648,TREATS,Bronchodilator Agents,risk factors,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0006280,C0039231,TREATS,Bronchodilator Agents,Tachycardia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0006280,C0277854,TREATS,Bronchodilator Agents,dyspneic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0006280,C0743630,TREATS,Bronchodilator Agents,exacerbation acute,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0006280,C1704258,TREATS,Bronchodilator Agents,Abnormality,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0006280,C3476546,TREATS,Bronchodilator Agents,Symptoms score,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0006280,C4086268,TREATS,Bronchodilator Agents,Exacerbation,phsu,fndg,4,TREATS_PHSUtrtsFNDG
C0006684,C0003811,TREATS,Calcium Channel Blockers,Cardiac Arrhythmia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0006684,C0039231,TREATS,Calcium Channel Blockers,Tachycardia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0006684,C0518609,TREATS,Calcium Channel Blockers,consideration,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0006881,C0232805,TREATS,Canrenoate Potassium,Normal renal function,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0007036,C0578862,TREATS,Carbonic Anhydrase Inhibitors,Intraocular pressure finding,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0007220,C0184511,TREATS,Cardiovascular Agents,Improved,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0008362,C0235266,TREATS,Choleretics,Eye irritation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0009905,C0392209,TREATS,"Contraceptives, Oral",Nutritional status,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0009905,C0439663,TREATS,"Contraceptives, Oral",Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0012191,C0221198,TREATS,Diethylcarbamazine,Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0012191,C4054987,TREATS,Diethylcarbamazine,Favorable Response,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0012341,C4289767,TREATS,Iodoquinol,Colonization,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0012798,C0003962,TREATS,Diuretics,Ascites,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0012798,C0020649,TREATS,Diuretics,Hypotension,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0012798,C0235266,TREATS,Diuretics,Eye irritation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0012798,C0259752,TREATS,Diuretics,Hyperosmolarity,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0012798,C0871269,TREATS,Diuretics,Rhythm,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0012798,C1998827,TREATS,Diuretics,Respiratory Status,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0012798,C3540840,TREATS,Diuretics,Sign or Symptom,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0013162,C0150312,TREATS,Drug Combinations,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0013162,C0332575,TREATS,Drug Combinations,Redness,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0013162,C0439663,TREATS,Drug Combinations,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0013162,C3272283,TREATS,Drug Combinations,American College of Cardiology/American Heart Association Lesion Complexity Score C,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0013230,C0231224,TREATS,Investigational New Drugs,Crisis,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0013230,C0439662,TREATS,Investigational New Drugs,Immune,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0013231,C0032972,TREATS,"Drugs, Non-Prescription",Pregnancy Outcome,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0013231,C0151849,TREATS,"Drugs, Non-Prescription",Alkaline phosphatase raised,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0013231,C0746467,TREATS,"Drugs, Non-Prescription",medication current,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0013231,C0814098,TREATS,"Drugs, Non-Prescription",health-related beliefs,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0013232,C0424601,TREATS,"Drugs, Orphan",General development,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0014432,C0231224,TREATS,Enzyme Inhibitors,Crisis,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0014921,C0086565,TREATS,Estramustine,Liver Dysfunction,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0015314,C1317600,TREATS,Expectorants,patient symptoms,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0015314,C1659989,TREATS,Expectorants,Respiratory problem,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0016018,C1998297,TREATS,Fibrinolytic Agents,Recent myocardial infarction,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0016018,C2959885,TREATS,Fibrinolytic Agents,Microthrombus,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0016018,C3277906,TREATS,Fibrinolytic Agents,Cardiac dysfunction,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0017302,C0235484,TREATS,General anesthetic drugs,cerebral hyperaemia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0019593,C0442797,TREATS,Histamine H2 Antagonists,Decreasing,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0019593,C4289767,TREATS,Histamine H2 Antagonists,Colonization,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0020316,C1320362,TREATS,Hydroxocobalamin,Suspected poisoning,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0020592,C0278140,TREATS,Hypnotics and Sedatives,Severe pain,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0020592,C2234351,TREATS,Hypnotics and Sedatives,neonatal Intubations,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0020616,C0241863,TREATS,Hypoglycemic Agents,diabetic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0022022,C0150312,TREATS,Ionophores,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0022260,C4035627,TREATS,Isotonic Solutions,2 times,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0024056,C0022107,TREATS,Loxapine,Irritable Mood,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0024911,C0038999,TREATS,Materia Medica,Swelling,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0024911,C0522224,TREATS,Materia Medica,Paralysed,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0026249,C0574776,TREATS,Mitogens,Wound healed (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0027409,C3714738,TREATS,Narcotic Analgesics,Compliance,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0027410,C1820738,TREATS,Narcotic Antagonists,Feeding Intolerance,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0027866,C0150312,TREATS,Neuromuscular Blocking Agents,Present,phsu,fndg,3,TREATS_PHSUtrtsFNDG
C0027866,C2316757,TREATS,Neuromuscular Blocking Agents,Increased creatine kinase level,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0030511,C0235229,TREATS,Parasympatholytics,Ciliary Body Spasm,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0030511,C3540840,TREATS,Parasympatholytics,Sign or Symptom,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0031638,C0349790,TREATS,Phosphodiesterase Inhibitors,Exacerbation of asthma,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0032838,C0150312,TREATS,Potassium Permanganate,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0033607,C0150312,TREATS,Protease Inhibitors,Present,phsu,fndg,5,TREATS_PHSUtrtsFNDG
C0033607,C0332149,TREATS,Protease Inhibitors,Possible,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0033607,C0439663,TREATS,Protease Inhibitors,Infected,phsu,fndg,3,TREATS_PHSUtrtsFNDG
C0033607,C0750484,TREATS,Protease Inhibitors,Confirmation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0033607,C1545588,TREATS,Protease Inhibitors,Protection,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0033607,C2004062,TREATS,Protease Inhibitors,History of previous events,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0033607,C4050171,TREATS,Protease Inhibitors,Sustained Virologic Response,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0033607,C4055506,TREATS,Protease Inhibitors,Accumulation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0033978,C0436345,TREATS,Psychotropic Drugs,Symptom severe,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0033978,C0728834,TREATS,Psychotropic Drugs,Place in family order: youngest sibling,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0036088,C0043352,TREATS,Artificial saliva,Xerostomia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0036557,C0235195,TREATS,Sedatives,Sedated state,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0036557,C3279537,TREATS,Sedatives,Severe brain damage,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0040615,C0043094,TREATS,Antipsychotic Agents,Weight Gain,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0040615,C0562359,TREATS,Antipsychotic Agents,Institutionalized,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0040616,C0085393,TREATS,Anti-Anxiety Agents,Immunocompromised Host,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0040616,C0241863,TREATS,Anti-Anxiety Agents,diabetic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0040616,C1148363,TREATS,Anti-Anxiety Agents,Hepatitis C virus genotype (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0040616,C3272283,TREATS,Anti-Anxiety Agents,American College of Cardiology/American Heart Association Lesion Complexity Score C,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0041044,C0035648,TREATS,Trimethoprim-Sulfamethoxazole Combination,risk factors,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0041044,C0311395,TREATS,Trimethoprim-Sulfamethoxazole Combination,Lameness,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0041044,C0439663,TREATS,Trimethoprim-Sulfamethoxazole Combination,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0041044,C0853142,TREATS,Trimethoprim-Sulfamethoxazole Combination,CD4 Lymphocytes Decreased,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0041044,C1557112,TREATS,Trimethoprim-Sulfamethoxazole Combination,CTCAE Grade 4 Opportunistic Infection,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0041044,C1859117,TREATS,Trimethoprim-Sulfamethoxazole Combination,Recurrent pulmonary infections,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0041044,C2029943,TREATS,Trimethoprim-Sulfamethoxazole Combination,Transplanted heart present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0041044,C3280118,TREATS,Trimethoprim-Sulfamethoxazole Combination,Mild disorder,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0041044,C3714738,TREATS,Trimethoprim-Sulfamethoxazole Combination,Compliance,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0041044,C3843708,TREATS,Trimethoprim-Sulfamethoxazole Combination,29+,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0041044,C3845888,TREATS,Trimethoprim-Sulfamethoxazole Combination,Known allergy,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0041044,C4296883,TREATS,Trimethoprim-Sulfamethoxazole Combination,Non-focal,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0042397,C0020649,TREATS,Vasoconstrictor Agents,Hypotension,phsu,fndg,10,TREATS_PHSUtrtsFNDG
C0042397,C0086565,TREATS,Vasoconstrictor Agents,Liver Dysfunction,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0042397,C0241311,TREATS,Vasoconstrictor Agents,post operative (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0042397,C0428886,TREATS,Vasoconstrictor Agents,Mean blood pressure,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0042397,C1299448,TREATS,Vasoconstrictor Agents,Patient ventilated,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0042397,C1444662,TREATS,Vasoconstrictor Agents,Discontinued,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0042397,C2585422,TREATS,Vasoconstrictor Agents,Hyperdynamic circulation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0042397,C3160731,TREATS,Vasoconstrictor Agents,Pulmonary function (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0042397,C4296962,TREATS,Vasoconstrictor Agents,Normal function,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0042397,C4321237,TREATS,Vasoconstrictor Agents,High Level,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0042398,C0429208,TREATS,Nasal Decongestants,Nasal resistance,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0054066,C0743630,TREATS,Amoxicillin / Clavulanate,exacerbation acute,phsu,fndg,3,TREATS_PHSUtrtsFNDG
C0054066,C3272281,TREATS,Amoxicillin / Clavulanate,American College of Cardiology/American Heart Association Lesion Complexity Score A,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0054066,C4086268,TREATS,Amoxicillin / Clavulanate,Exacerbation,phsu,fndg,7,TREATS_PHSUtrtsFNDG
C0056331,C0150312,TREATS,cordycepin,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0074176,C0086565,TREATS,schizandrin C,Liver Dysfunction,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0074176,C1545588,TREATS,schizandrin C,Protection,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0074690,C0221198,TREATS,Smectite,Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0077073,C0235195,TREATS,triclofos,Sedated state,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0077102,C0150312,TREATS,triethylenediamine,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0078516,C0038187,TREATS,World Health Organization oral rehydration solution,Starvation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0078516,C0546884,TREATS,World Health Organization oral rehydration solution,Hypovolemia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0079044,C0234422,TREATS,Bronchoconstrictor Agents,Awake,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0079044,C1720436,TREATS,Bronchoconstrictor Agents,Under anesthesia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0085385,C0853085,TREATS,Lipoxygenase Inhibitors,Decreased LDL,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0085387,C0158915,TREATS,Cyclooxygenase Inhibitors,Exceptionally large baby (disorder),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0119394,C0221198,TREATS,GLUCEPTATE,Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0120742,C0150312,TREATS,Hanks Balanced Salt Solution,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0162713,C0221198,TREATS,Photosensitizing Agents,Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0205946,C1836348,TREATS,Antischistosomal Agents,Severe disorder,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0206795,C0221198,TREATS,alovudine,Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0242708,C0150312,TREATS,"Antirheumatic Drugs, Disease-Modifying",Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0242708,C3272281,TREATS,"Antirheumatic Drugs, Disease-Modifying",American College of Cardiology/American Heart Association Lesion Complexity Score A,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0242896,C4086268,TREATS,Anticholinergic Agents,Exacerbation,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0242904,C0581126,TREATS,"Anesthetics, Intravenous",Severe asthma,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0242937,C0278138,TREATS,"Analgesics, Non-Narcotic",Mild pain,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0242974,C0235195,TREATS,GABA Agonists,Sedated state,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0250480,C0749647,TREATS,piperacillin-tazobactam combination,treatment empiric,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0282090,C0205160,TREATS,Laxatives,Negative,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0282374,C0337664,TREATS,Decongestants,Smoker,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0282519,C1836348,TREATS,Reverse Transcriptase Inhibitors,Severe disorder,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0282568,C0231170,TREATS,"Drugs, Essential",Disability,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0282568,C0231224,TREATS,"Drugs, Essential",Crisis,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0302232,C1659989,TREATS,Demulcent,Respiratory problem,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0302837,C0456909,TREATS,Vitamin supplementation,Blindness,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0304509,C0150312,TREATS,Inotropic agent,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0304604,C0033774,TREATS,Topical form corticosteroids,Pruritus,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0304604,C0221198,TREATS,Topical form corticosteroids,Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0304604,C3540840,TREATS,Topical form corticosteroids,Sign or Symptom,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0309989,C0007294,TREATS,quantum,Genetic Carriers,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0309989,C0392349,TREATS,quantum,information seeking,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0310255,C0221198,TREATS,survive,Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0310255,C0425945,TREATS,survive,Prolonged menses,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0310255,C3842672,TREATS,survive,Day 7,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0353043,C0150312,TREATS,Cleansing preparations,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0354100,C0003962,TREATS,Loop Diuretics,Ascites,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0358430,C0235195,TREATS,Muscle relaxants,Sedated state,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0358591,C0150312,TREATS,Proton Pump Inhibitors,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0358591,C0332155,TREATS,Proton Pump Inhibitors,Did not receive therapy or drug for,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0358591,C0439663,TREATS,Proton Pump Inhibitors,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0359086,C0518609,TREATS,Oral hypoglycemic,consideration,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0360105,C0038661,TREATS,Selective Serotonin Reuptake Inhibitors,Suicide,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0360703,C0080203,TREATS,Class III antiarrhythmic drug,Tachyarrhythmia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0376447,C0392209,TREATS,Appetite Stimulants,Nutritional status,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0376565,C0150312,TREATS,Anti-HIV Agents,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0376565,C0184511,TREATS,Anti-HIV Agents,Improved,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0376565,C0439663,TREATS,Anti-HIV Agents,Infected,phsu,fndg,5,TREATS_PHSUtrtsFNDG
C0443121,C0150312,TREATS,Cryoprecipitate,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0456388,C0150312,TREATS,Blood product,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0456388,C0231224,TREATS,Blood product,Crisis,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0456388,C0442797,TREATS,Blood product,Decreasing,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0456388,C0677946,TREATS,Blood product,Stable Disease,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0459106,C0150312,TREATS,Nitrate agent,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0521942,C0009488,TREATS,Angiotensin II receptor antagonist,Comorbidity,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0521942,C0439663,TREATS,Angiotensin II receptor antagonist,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0544357,C0150312,TREATS,human plasma,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0544357,C0701159,TREATS,human plasma,Patient in hospital,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0592018,C0020649,TREATS,prowess,Hypotension,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0597104,C0439663,TREATS,nucleoside inhibitor,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0597668,C0150312,TREATS,vitamin antagonist,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0598695,C0438696,TREATS,NMDA receptor antagonist,Suicidal,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0599685,C0439663,TREATS,Anti-Retroviral Agents,Infected,phsu,fndg,4,TREATS_PHSUtrtsFNDG
C0599685,C0679254,TREATS,Anti-Retroviral Agents,disease recurrence,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0600437,C4086268,TREATS,Nitric Oxide Donors,Exacerbation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0601906,C0150312,TREATS,PH.3,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0642334,C0150312,TREATS,N(2)-(3-trifluoromethylphenyl)guanine,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0684286,C0221198,TREATS,antiatherogenic agent,Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0696679,C0003962,TREATS,Astragalus propinquus root extract,Ascites,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0699149,C0150312,TREATS,C-Long,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0718215,C0017187,TREATS,ACIDOPHILUS,Gastrointestinal problem,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0718215,C0686744,TREATS,ACIDOPHILUS,Well child,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0719214,C0035648,TREATS,century,risk factors,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0719214,C0150312,TREATS,century,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0719214,C0424575,TREATS,century,General health,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0719214,C0424589,TREATS,century,Vitality,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0719214,C0595998,TREATS,century,Household composition,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0719214,C0871269,TREATS,century,Rhythm,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0719214,C1318963,TREATS,century,Readiness,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0719214,C1516998,TREATS,century,Exogenous Factors,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0719214,C3843057,TREATS,century,Second half,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0728749,C3843504,TREATS,Redux,1 - 3,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0770565,C0746866,TREATS,Dexamethasone phosphate,Neurological status,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0770667,C0332155,TREATS,Nifuraldezone,Did not receive therapy or drug for,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0872285,C1299586,TREATS,therapeutic protein,Has difficulty doing (qualifier value),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0875962,C0033213,TREATS,Anti-Gas,Problem,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0878260,C0150312,TREATS,Auramine O,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0907767,C0221198,TREATS,"N(6)-cyclopropyl-9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine",Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0911981,C0150312,TREATS,oocydin A,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0914297,C0679246,TREATS,oblimersen,advanced disease,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0936150,C3272281,TREATS,artemether / lumefantrine,American College of Cardiology/American Heart Association Lesion Complexity Score A,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0939237,C0035648,TREATS,lopinavir / Ritonavir,risk factors,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0939237,C0151878,TREATS,lopinavir / Ritonavir,Prolonged QT interval,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0939237,C0332149,TREATS,lopinavir / Ritonavir,Possible,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0939237,C0439662,TREATS,lopinavir / Ritonavir,Immune,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0939237,C0439663,TREATS,lopinavir / Ritonavir,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0939237,C0679250,TREATS,lopinavir / Ritonavir,Disease Outcome,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C0939237,C0683521,TREATS,lopinavir / Ritonavir,patient condition,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0939237,C1444662,TREATS,lopinavir / Ritonavir,Discontinued,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0939237,C1836775,TREATS,lopinavir / Ritonavir,Mild disease course,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0939237,C1848676,TREATS,lopinavir / Ritonavir,Normal liver function,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0939237,C2004062,TREATS,lopinavir / Ritonavir,History of previous events,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0939237,C3811922,TREATS,lopinavir / Ritonavir,Liver transplant recipient,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0939806,C0262477,TREATS,Matricaria recutita extract,Eye problem,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0949854,C0439663,TREATS,Plant Preparations,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0949854,C1262477,TREATS,Plant Preparations,Weight decreased,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0961026,C0439663,TREATS,"(2,2-bis(docosyloxymethyl)propyl-5-acetamido-3,5-dideoxy-4,7,8,9-tetra-O-(sodium oxysulfonyl)glycero-alpha-galacto-2-nonulopyranosid)onate",Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0968269,C0221198,TREATS,luteoforol,Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0971524,C1545588,TREATS,zoniporide,Protection,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C0995194,C0679246,TREATS,PRO-542,advanced disease,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1122050,C0442797,TREATS,BAY 57-1293,Decreasing,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1134558,C1706753,TREATS,Chinese herbs,Aggravated Disease,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0043084,TREATS,Microbicides,Weaning,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0150312,TREATS,Microbicides,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0221198,TREATS,Microbicides,Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0235896,TREATS,Microbicides,Pulmonary Infiltrate,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0240807,TREATS,Microbicides,PROGRESSIVE SYMPTOMS,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0332149,TREATS,Microbicides,Possible,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0332219,TREATS,Microbicides,Easy,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0349790,TREATS,Microbicides,Exacerbation of asthma,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0424768,TREATS,Microbicides,Prolonged fever,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0425946,TREATS,Microbicides,Short menstrual periods,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0427965,TREATS,Microbicides,Antimicrobial susceptibility,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0439663,TREATS,Microbicides,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0520819,TREATS,Microbicides,Decreased pressure,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0560175,TREATS,Microbicides,Carrier of disorder,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1136254,C0743630,TREATS,Microbicides,exacerbation acute,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0749647,TREATS,Microbicides,treatment empiric,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0750479,TREATS,Microbicides,blank,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C0750558,TREATS,Microbicides,Unlikely,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C1299586,TREATS,Microbicides,Has difficulty doing (qualifier value),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C1318963,TREATS,Microbicides,Readiness,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C3242274,TREATS,Microbicides,new therapy,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C3266799,TREATS,Microbicides,Wound dressing,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C3272281,TREATS,Microbicides,American College of Cardiology/American Heart Association Lesion Complexity Score A,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1136254,C3272283,TREATS,Microbicides,American College of Cardiology/American Heart Association Lesion Complexity Score C,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136254,C4086268,TREATS,Microbicides,Exacerbation,phsu,fndg,4,TREATS_PHSUtrtsFNDG
C1136254,C4264624,TREATS,Microbicides,Likely pathogenic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1136312,C0349790,TREATS,"Histamine H1 Antagonists, Non-Sedating",Exacerbation of asthma,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1254211,C0206076,TREATS,Ilex paraguayensis homeopathic preparation,Reproductive History,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1258800,C2598387,TREATS,Anabolic Agents,Overall status,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1268551,C2923839,TREATS,Echinocandins,Risk level,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1268865,C0442797,TREATS,Prokinetic Agent,Decreasing,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1268865,C1820738,TREATS,Prokinetic Agent,Feeding Intolerance,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1268919,C0085393,TREATS,Fungal product,Immunocompromised Host,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1276807,C0429706,TREATS,Budesonide / formoterol,Forced expiratory volume in 1 second finding,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1318700,C0242350,TREATS,Phosphodiesterase 5 inhibitor,Erectile dysfunction,phsu,fndg,3,TREATS_PHSUtrtsFNDG
C1330330,C3714738,TREATS,Hand Sanitizers,Compliance,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1360419,C4068826,TREATS,Herbal Drugs,Harsh,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1443643,C0033213,TREATS,Proteasome inhibitor,Problem,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1443650,C0009488,TREATS,Neuraminidase inhibitor,Comorbidity,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1443650,C0085393,TREATS,Neuraminidase inhibitor,Immunocompromised Host,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1443650,C0701159,TREATS,Neuraminidase inhibitor,Patient in hospital,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1443650,C3840916,TREATS,Neuraminidase inhibitor,4-5 days,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1509509,C0600457,TREATS,Filamentous haemagglutinin adsorbed,Gravidity,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1513344,C0150312,TREATS,Mitogen-Activated Protein Kinase Inhibitor,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1514669,C0686750,TREATS,RNA Polymerase Inhibitor,Well adult,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1514727,C3272283,TREATS,Ras Inhibitor,American College of Cardiology/American Heart Association Lesion Complexity Score C,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1516312,C0150312,TREATS,Caspase Inhibitors,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1516312,C0596013,TREATS,Caspase Inhibitors,Does stand,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1520007,C0033213,TREATS,viral vector,Problem,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1520007,C0232370,TREATS,viral vector,Florid red complexion (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1520007,C0238646,TREATS,viral vector,ANIMAL EXPOSURE,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1520007,C1299586,TREATS,viral vector,Has difficulty doing (qualifier value),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1520007,C4321237,TREATS,viral vector,High Level,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1563745,C3272283,TREATS,Selective Angiotensin II Receptor Antagonists,American College of Cardiology/American Heart Association Lesion Complexity Score C,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1709545,C0456240,TREATS,Piperine Extract (Standardized),Core body temperature,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1718097,C0038435,TREATS,New medications,Stress,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1718097,C0085393,TREATS,New medications,Immunocompromised Host,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1718097,C0333361,TREATS,New medications,Acute inflammation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1718097,C0746467,TREATS,New medications,medication current,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1718097,C1838994,TREATS,New medications,Rapid onset,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1827106,C0241863,TREATS,Dipeptidyl-Peptidase IV Inhibitors,diabetic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1831996,C0003962,TREATS,DTA-H19 plasmid,Ascites,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874271,C0221198,TREATS,Topical antibacterial,Lesion,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1874451,C0005911,TREATS,Basis,Body Weight Changes,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1874451,C0009488,TREATS,Basis,Comorbidity,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0020461,TREATS,Basis,Hyperkalemia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0026751,TREATS,Basis,Multiparity,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0035648,TREATS,Basis,risk factors,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0038435,TREATS,Basis,Stress,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0086439,TREATS,Basis,Hypokinesia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0087130,TREATS,Basis,Uncertainty,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0150312,TREATS,Basis,Present,phsu,fndg,4,TREATS_PHSUtrtsFNDG
C1874451,C0184511,TREATS,Basis,Improved,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1874451,C0205160,TREATS,Basis,Negative,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0221198,TREATS,Basis,Lesion,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1874451,C0231221,TREATS,Basis,Asymptomatic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0231224,TREATS,Basis,Crisis,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1874451,C0232370,TREATS,Basis,Florid red complexion (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0241863,TREATS,Basis,diabetic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0277787,TREATS,Basis,Social stigmata,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0332148,TREATS,Basis,Probable diagnosis,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1874451,C0332149,TREATS,Basis,Possible,phsu,fndg,3,TREATS_PHSUtrtsFNDG
C1874451,C0332509,TREATS,Basis,Increased size (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0340871,TREATS,Basis,Relative hypovolemia,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1874451,C0344339,TREATS,Basis,Family illness,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0376705,TREATS,Basis,Viral Load result,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0392209,TREATS,Basis,Nutritional status,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1874451,C0425152,TREATS,Basis,Engaged to be married,phsu,fndg,6,TREATS_PHSUtrtsFNDG
C1874451,C0442726,TREATS,Basis,Detected (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0442797,TREATS,Basis,Decreasing,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1874451,C0474396,TREATS,Basis,Sleep behavior finding,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0518609,TREATS,Basis,consideration,phsu,fndg,4,TREATS_PHSUtrtsFNDG
C1874451,C0521654,TREATS,Basis,Neurologic Deficits,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0521874,TREATS,Basis,Victim of neglect (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0574125,TREATS,Basis,Functional finding,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0595998,TREATS,Basis,Household composition,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0679250,TREATS,Basis,Disease Outcome,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0743630,TREATS,Basis,exacerbation acute,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0749647,TREATS,Basis,treatment empiric,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C0750484,TREATS,Basis,Confirmation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C1262477,TREATS,Basis,Weight decreased,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C1281905,TREATS,Basis,At risk of disease,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C1290905,TREATS,Basis,Discrepancy,phsu,fndg,5,TREATS_PHSUtrtsFNDG
C1874451,C1290916,TREATS,Basis,Radiologic finding,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C1299487,TREATS,Basis,Patient name,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C1446614,TREATS,Basis,Convergent gaze,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C1545588,TREATS,Basis,Protection,phsu,fndg,4,TREATS_PHSUtrtsFNDG
C1874451,C1709157,TREATS,Basis,Negative Surgical Margin,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C1837385,TREATS,Basis,Poor growth,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C1837514,TREATS,Basis,Phenotypic Variation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C3151659,TREATS,Basis,Auditory impairment,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C3242274,TREATS,Basis,new therapy,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C3258145,TREATS,Basis,Secondary problem,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C3272283,TREATS,Basis,American College of Cardiology/American Heart Association Lesion Complexity Score C,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C3273245,TREATS,Basis,Acute Rejection,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1874451,C3540840,TREATS,Basis,Sign or Symptom,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1874451,C4055506,TREATS,Basis,Accumulation,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C1874451,C4321237,TREATS,Basis,High Level,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1875235,C0740852,TREATS,Helium / Oxygen,Upper airway obstruction,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1875376,C2919051,TREATS,INVESTIGATIONAL GENE THERAPY,Ischemic Myocardium,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1875784,C0476644,TREATS,STEP 2,Physical and emotional exhaustion state,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1875784,C1854293,TREATS,STEP 2,Iterations,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1875784,C3714738,TREATS,STEP 2,Compliance,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1883555,C0443213,TREATS,Whey Protein Isolate,Extrusion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C1998014,C3280118,TREATS,Denufosol,Mild disorder,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2215699,C0003962,TREATS,Mineralocorticoid Receptor blockers,Ascites,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2347168,C0033213,TREATS,Mitogen-Activated Protein Kinase Kinase Inhibitor,Problem,phsu,fndg,3,TREATS_PHSUtrtsFNDG
C2347168,C0150312,TREATS,Mitogen-Activated Protein Kinase Kinase Inhibitor,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2348075,C3890735,TREATS,darapladib,Complete Response with Incomplete Platelet Recovery,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2697995,C3842672,TREATS,MultiStem,Day 7,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2698842,C0043094,TREATS,hiltonol,Weight Gain,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2719416,C0150312,TREATS,Vortex,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2723461,C0424561,TREATS,ulipristal acetate,Bleeds profusely,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2743950,C0231224,TREATS,Oxyglobin,Crisis,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2746051,C0600457,TREATS,DNA Polymerase Inhibitors,Gravidity,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2746052,C1444662,TREATS,mTOR Inhibitor,Discontinued,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2917414,C0150312,TREATS,Recombinant Human Deoxyribonuclease 1 [EPC],Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2930041,C0035648,TREATS,Ampicillin / Sulbactam,risk factors,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2954564,C0150312,TREATS,Suppressor,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2954564,C1864829,TREATS,Suppressor,Praxis,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2954564,C4321237,TREATS,Suppressor,High Level,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C0009488,TREATS,Agonist,Comorbidity,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C0020649,TREATS,Agonist,Hypotension,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C0038435,TREATS,Agonist,Stress,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C0039231,TREATS,Agonist,Tachycardia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C0150312,TREATS,Agonist,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C0235195,TREATS,Agonist,Sedated state,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C0235896,TREATS,Agonist,Pulmonary Infiltrate,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C0237284,TREATS,Agonist,unresponsive behavior,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C0241863,TREATS,Agonist,diabetic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C0521654,TREATS,Agonist,Neurologic Deficits,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C1299586,TREATS,Agonist,Has difficulty doing (qualifier value),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C1545588,TREATS,Agonist,Protection,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C3476546,TREATS,Agonist,Symptoms score,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C2987634,C3843256,TREATS,Agonist,Line 11,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C4086268,TREATS,Agonist,Exacerbation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C4321237,TREATS,Agonist,High Level,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C2987634,C4534306,TREATS,Agonist,Supplemental oxygen,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3166216,C0241863,TREATS,Prescribed medications,diabetic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3191774,C1545588,TREATS,Methanol Solution,Protection,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3241999,C0439663,TREATS,limited use,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3256468,C0150312,TREATS,citrate buffer,Present,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C3256935,C0150312,TREATS,sodium phosphate buffer,Present,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C3537002,C0429306,TREATS,Anti-epileptic Agent [EPC],Burst suppression,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3537218,C0750484,TREATS,Neuraminidase Inhibitor [EPC],Confirmation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3537218,C1836348,TREATS,Neuraminidase Inhibitor [EPC],Severe disorder,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0021294,TREATS,other medicated shampoos in ATC,"Infant, Premature",phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0037420,TREATS,other medicated shampoos in ATC,Social Interaction,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C3539125,C0150312,TREATS,other medicated shampoos in ATC,Present,phsu,fndg,5,TREATS_PHSUtrtsFNDG
C3539125,C0221198,TREATS,other medicated shampoos in ATC,Lesion,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0231221,TREATS,other medicated shampoos in ATC,Asymptomatic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0231224,TREATS,other medicated shampoos in ATC,Crisis,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0231303,TREATS,other medicated shampoos in ATC,Distress,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0241863,TREATS,other medicated shampoos in ATC,diabetic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0262926,TREATS,other medicated shampoos in ATC,Medical History,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0392209,TREATS,other medicated shampoos in ATC,Nutritional status,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0439663,TREATS,other medicated shampoos in ATC,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0476644,TREATS,other medicated shampoos in ATC,Physical and emotional exhaustion state,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0489618,TREATS,other medicated shampoos in ATC,pupil diameter,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0549336,TREATS,other medicated shampoos in ATC,asthma aggravated,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0577305,TREATS,other medicated shampoos in ATC,Multiple lesions,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0681405,TREATS,other medicated shampoos in ATC,preschool,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0683314,TREATS,other medicated shampoos in ATC,personal health,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C0750479,TREATS,other medicated shampoos in ATC,blank,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C3539125,C0750484,TREATS,other medicated shampoos in ATC,Confirmation,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C3539125,C0848894,TREATS,other medicated shampoos in ATC,normal patient,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C1281905,TREATS,other medicated shampoos in ATC,At risk of disease,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C1320226,TREATS,other medicated shampoos in ATC,Incubation period,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C1844666,TREATS,other medicated shampoos in ATC,Immune dysregulation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C3272281,TREATS,other medicated shampoos in ATC,American College of Cardiology/American Heart Association Lesion Complexity Score A,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C3272283,TREATS,other medicated shampoos in ATC,American College of Cardiology/American Heart Association Lesion Complexity Score C,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C3539125,C3641827,TREATS,other medicated shampoos in ATC,Agree,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C3687379,TREATS,other medicated shampoos in ATC,Lateral recumbency,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C3810115,TREATS,other medicated shampoos in ATC,Normal B cells,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C3816499,TREATS,other medicated shampoos in ATC,Pathogenic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C3840880,TREATS,other medicated shampoos in ATC,Traffic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C3890735,TREATS,other medicated shampoos in ATC,Complete Response with Incomplete Platelet Recovery,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C4055506,TREATS,other medicated shampoos in ATC,Accumulation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C4068826,TREATS,other medicated shampoos in ATC,Harsh,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C4086268,TREATS,other medicated shampoos in ATC,Exacerbation,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539125,C4289767,TREATS,other medicated shampoos in ATC,Colonization,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539193,C0150312,TREATS,"Imidazole derivatives, antimycotic for systemic use",Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539957,C0150312,TREATS,opium alkaloids and derivative combination cough suppressants,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539957,C0332149,TREATS,opium alkaloids and derivative combination cough suppressants,Possible,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3539957,C0332575,TREATS,opium alkaloids and derivative combination cough suppressants,Redness,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3541969,C0085393,TREATS,"Neuraminidase inhibitors, direct acting antivirals",Immunocompromised Host,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3541969,C0087130,TREATS,"Neuraminidase inhibitors, direct acting antivirals",Uncertainty,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3541969,C0686750,TREATS,"Neuraminidase inhibitors, direct acting antivirals",Well adult,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C3541969,C0701159,TREATS,"Neuraminidase inhibitors, direct acting antivirals",Patient in hospital,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C3541969,C1836348,TREATS,"Neuraminidase inhibitors, direct acting antivirals",Severe disorder,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3541969,C3272283,TREATS,"Neuraminidase inhibitors, direct acting antivirals",American College of Cardiology/American Heart Association Lesion Complexity Score C,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3543842,C0015663,TREATS,TONICS,Fasting,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3543842,C0231162,TREATS,TONICS,Normal general body function,phsu,fndg,2,TREATS_PHSUtrtsFNDG
C3543842,C0241863,TREATS,TONICS,diabetic,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3543842,C0242350,TREATS,TONICS,Erectile dysfunction,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3543842,C0424589,TREATS,TONICS,Vitality,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3543842,C1272641,TREATS,TONICS,Systemic arterial pressure,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3543842,C1631070,TREATS,TONICS,6/4.5,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3653501,C0439663,TREATS,DIRECT ACTING ANTIVIRALS,Infected,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3653788,C0020461,TREATS,ANTIANEMIC PREPARATIONS,Hyperkalemia,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3653788,C3665437,TREATS,ANTIANEMIC PREPARATIONS,Serum phosphate concentrations above normal (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3654000,C0422837,TREATS,SENSORY ORGAN DRUGS,Neurological observations,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3656593,C0686750,TREATS,ceftolozane / tazobactam,Well adult,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3659863,C0686750,TREATS,V710 vaccine,Well adult,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3661039,C1545588,TREATS,WDO-217,Protection,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3838940,C1838994,TREATS,Stonefish antivenom,Rapid onset,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3853872,C3280502,TREATS,electrolyte solution,"Diarrhea, malabsorptive",phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3854325,C1836348,TREATS,Janus kinase inhibitor,Severe disorder,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3854325,C1850165,TREATS,Janus kinase inhibitor,Elevated IL6,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3858051,C1148363,TREATS,ledipasvir / sofosbuvir,Hepatitis C virus genotype (finding),phsu,fndg,1,TREATS_PHSUtrtsFNDG
C3883357,C0150312,TREATS,Hepatitis C Virus NS5A Inhibitor [EPC],Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C4305867,C4531251,TREATS,Sirna-027,Subfoveal choroidal neovascularization,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C4330852,C0150312,TREATS,Oligomeric Procyanidin Complex,Present,phsu,fndg,1,TREATS_PHSUtrtsFNDG
C4331423,C0518609,TREATS,Traditional Chinese Medicine Formulation,consideration,phsu,fndg,1,TREATS_PHSUtrtsFNDG
